Pharmaceutical CAS 16590-41-3 Naltrexone Powder Naltrexone Hydrochloride Naltrexone

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >99%
• Model NO.: D-sung Naltrexone
• Product Name: Naltrexone
• Name: Naltrexone Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 16590-41-3
• Mf: C20h23no4
• Boiling Point: 558.1
• Melting Point: 168-170
• Density: 1.47
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 1000kg/Month

Product Description

Pharmaceutical CAS 16590-41-3 Naltrexone Powder Naltrexone Hydrochloride Naltrexone

Product Description

Product Details

Product Name	Naltrexone
CAS	16590-41-3
Appearance	White crystalline powder
MF	C20H23NO4
MW	341.407
Purity	99%
Shelf Life	2 Years

Naltrexone is a medication primarily used to manage alcohol or opioid dependence. An opioid-dependent person should not receive naltrexone before detoxification. It is taken by mouth or by injection into a muscle. Effects begin within 30 minutes. A decreased desire for opioids, though, may take a few weeks.

 

Application&Function

Naloxone hydrochloride occurs as a white to slightly off-white powder, and is soluble in water, in dilute acids, and in strong alkali; slightly soluble in alcohol; practically insoluble in ether.
Naloxone hydrochloride injection is available as a sterile solution for intravenous, intramuscular, and subcutaneous administration. Each mL contains 0.4 mg of Naloxone hydrochloride. Each mL contains 8.9 mg of sodium chloride. The pH is adjusted between 3.0 to 6.5. The air in the cartridges has been displaced by nitrogen gas.
The most common side effects reported with naltrexone are gastrointestinal complaints such as diarrhea and abdominal cramping.
These adverse effects are analogous to the symptoms of withdrawal, as the mu receptor blockade will increase GI motility.
 

Specification